An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations
Dec 6, 2019
Published in: Journal of General Internal Medicine, Volume 35, page 2475 (2020). doi: 10.1007/s11606-020-05791-5
Posted on RAND.org on April 13, 2021
We appreciate the response from Truong, Patil, and Rich to our study regarding retail pharmacy naloxone prescriptions and thank them for highlighting the importance of patient and caregiver education for individuals receiving naloxone. While naloxone is generally considered a safe medication, like almost all medications, there are risks of unintended adverse consequences if not used as intended. It is essential that prescribers educate patients and caregivers regarding the circumstances when naloxone should be administered, and the procedures for administering it, when writing a naloxone prescription. In addition, since nearly all states have laws or policies that allow individuals to obtain naloxone from a pharmacist without a prescription from a physician, pharmacists also play a critical role in counseling patients and caregivers regarding the circumstances when naloxone should be administered and proper procedures for administration.